Weijian Liu

Weijian Liu

Auto-generated profile, based on publicly available information

Weijian Liu

Department of Psychiatry Amsterdam UMC location University of Amsterdam Amsterdam the Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of Affective Disorders
Verified
Journal Article
Closed access
XLXiaofeng Lan
Xiaofeng Lan
YZYanling Zhou
Yanling Zhou
Wei ZhengWei Zheng
Wei Zheng
YZYanni Zhan
Yanni Zhan
WLWeijian Liu
Weijian Liu
YNYuping Ning
Yuping Ning

28 December 2021 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
MWMingqia Wang
Mingqia Wang
XCXiaoyu Chen
Xiaoyu Chen
YHYiru Hu
Yiru Hu
YZYangling Zhou
Yangling Zhou
CWChengyu Wang
Chengyu Wang
BZBin Zhang
Bin Zhang

31 August 2024 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Open access
PDF file
WLWeijian Liu
Weijian Liu
JHJurjen Heij
Jurjen Heij
SLShu Liu
Shu Liu
LLLuka Liebrand
Luka Liebrand
MCMatthan Caan
Matthan Caan
GWGuido van Wingen
Guido van Wingen
Morphological changes in the hippocampal, thalamic, and amygdala subfields have been suggested to form part of the pathophysiology of major depressive disorder (MDD). However, the use of conventional MRI scanners and acquisition techniques has prevented in-depth examinations at the subfield level, precluding a fine-grained understanding of these subfields and their involvement in MDD pathophysiology. We uniquely employed ultra-high field MRI at 7.0 Tesla to map hippocampal, thalamic, and amygdala subfields in MDD. Fifty-six MDD patients and 14 healthy controls (HCs) were enrolled in the final analysis. FreeSurfer protocols were used to segment hippocampal, thalamic, and amygdala subfields. Bayesian analysis was then implemented to assess differences between groups and relations with clinical features. While no effect was found for MDD diagnosis (i.e., case–control comparison), clinical characteristics of MDD patients were associated with subfield volumes of the hippocampus, thalamus, and amygdala. Specifically, the severity of depressive symptoms, insomnia, and childhood trauma in MDD patients related to lower thalamic subfield volumes. In addition, MDD patients with typical MDD versus those with atypical MDD showed lower hippocampal, thalamic, and amygdala subfield volumes. MDD patients with recurrent MDD versus those with first-episode MDD also showed lower thalamic subfield volumes. These findings allow uniquely fine-grained insights into hippocampal, thalamic, and amygdala subfield morphology in MDD, linking some of them to the clinical manifestation of MDD.

4 November 2024 in Journal of Affective Disorders
Verified
Journal Article
Open access
WLWeijian Liu
Weijian Liu
JHJurjen Heij
Jurjen Heij
SLShu Liu
Shu Liu
LLLuka Liebrand
Luka Liebrand
MCMatthan Caan
Matthan Caan
GWGuido van Wingen
Guido van Wingen
The thalamus serves as a central relay station within the brain, and thalamic connectional anomalies are increasingly thought to be present in major depressive disorder (MDD). However, the use of conventional MRI scanners and acquisition techniques has prevented a thorough examination of the thalamus and its subnuclear connectional profile. We combined ultra-high field diffusion MRI acquired at 7.0 Tesla to map the white matter connectivity of thalamic subnuclei. Fifty-three MDD patients and 12 healthy controls (HCs) were involved in the final analysis. FreeSurfer was used to segment the thalamic subnuclei, and MRtrix was used to perform the preprocessing and tractography. Fractional anisotropy, axial diffusivity, mean diffusivity, radial diffusivity, and streamline count of thalamic subnuclear tracts were measured as proxies of white matter microstructure. Bayesian multilevel model was used to assess group differences in white matter metrics for each thalamic subnuclear tract and the association between these white matter metrics and clinical features in MDD. Evidence was found for reduced whiter matter metrics of the tracts spanning from all thalamic subnuclei among MDD versus HC participants. Moreover, evidence was found that white matter in various thalamic subnuclear tracts is related to medication status, age of onset and recurrence in MDD. Structural connectivity was generally reduced in thalamic subnuclei in MDD participants. Several clinical characteristics are related to perturbed subnuclear thalamic connectivity with cortical and subcortical circuits that govern sensory processing, emotional function, and goal-directed behavior.

27 September 2024 in European Neuropsychopharmacology
Verified
Journal Article
Open access
WLWeijian Liu
Weijian Liu
JHJurjen Heij
Jurjen Heij
SLShu Liu
Shu Liu
LLLuka Liebrand
Luka Liebrand
MCMatthan Caan
Matthan Caan
GWGuido van Wingen
Guido van Wingen
Accumulating evidence points to imbalanced dopamine (DA) signaling and circulating levels in the pathophysiology of major depressive disorder (MDD). However, the use of conventional MRI scanners and acquisition techniques has prevented a thorough examination of DA neural pathways in MDD. We uniquely employed ultrahigh field diffusion MRI at 7.0 Tesla to map the white matter architecture and integrity of several DA pathways in MDD patients. Fifty-three MDD patients and 12 healthy controls (HCs) were enrolled in the final analysis. Images were acquired using a 7.0 Tesla MRI scanner. FreeSurfer was used to segment components of DA pathways, and MRtrix was used to perform preprocessing and tractography of mesolimbic, mesocortical, nigrostriatal, and unconventional DA pathways. Bayesian analyses assessed the impact of MDD and clinical features on DA tracts. MDD was associated with perturbed white matter microstructural properties of the nigrostriatal pathway, while several MDD features (severity of depression/age of onset/insomnia) related to connectivity changes within mesocortical, nigrostriatal, and unconventional pathways. MDD is associated with microstructural differences in the nigrostriatal pathway. The findings provide insight into the structural architecture and integrity of several DA pathways in MDD, and implicate their involvement in the clinical manifestation of MDD.

11 March 2026 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Open access
WLWeijian Liu
Weijian Liu
SLShu Liu
Shu Liu
JHJurjen Heij
Jurjen Heij
LMLaurens A. van de Mortel
Laurens A. van de Mortel
LLLuka Liebrand
Luka Liebrand
GWGuido van Wingen
Guido van Wingen
Aims: Major depressive disorder (MDD) is widely considered to be a mood disorder characterized by altered connectivity. The thalamus plays an important role in MDD by connecting large areas of the brain. Here, we explored thalamic connectivity in MDD at the subnuclear level using ultra‐high‐field MRI. Methods: We combined ultra‐high‐field functional and diffusion MRI at 7.0 Tesla to map the connectivity of thalamic subnuclei in MDD patients ( n = 47) and healthy controls ( n = 13). We segmented thalamic subnuclei and calculated the functional and structural connectivity of thalamic subnuclei and tested for group differences and associations with clinical characteristics. Results: MDD patients showed increased functional connectivity of the right thalamic central lateral nucleus with the right amygdala, bilateral inferior occipital lobe, and right transverse temporal gyrus, which was accompanied by increased structural connectivity between the right thalamic central lateral nucleus and the right inferior occipital lobe. Medicated MDD patients had a greater streamline count of the right thalamic central lateral nucleus–right inferior occipital lobe tract than healthy controls. Conclusions: Thalamic subnuclear connectivity with cortical and subcortical brain regions is perturbed in MDD. These results further support increased thalamic connectivity in MDD and suggest that this is related to a specific subnucleus.